Subscribe to Newsletter
Outside the Lab Screening and monitoring, Oncology, Genetics and epigenetics, Technology and innovation, Omics

Determining tumour mutation burden using Oncomine Tumour Mutation Load Assay

sponsored by Thermo Fisher Scientific

The Pathologist and Thermo Fisher Scientific are giving you the opportunity to delve into tumour mutation burden, and one of the best ways to ascertain it – Oncomine Tumour Mutation Load Assay.

Dr José Carlos Machado, vice-president of the Institute of Molecular Pathology and Immunology at the University of Porto, will take you through the popularity of tumour mutation load as an immunotherapy biomarker, the optimal use for NGS panels for biomarkers, and more.

Learning objectives of webinar:
  • Why tumour mutation load is an emerging biomarker for immuno checkpoint therapy
  • How an NGS research target panel can be used to determine mutation load biomarker in 2 days workflow
  • Discuss how you can easily implement on clinical research samples in your laboratory

View on-demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register